A
apoQlar
Powering the Future of Surgical Care & Medical Education in Mixed Reality
About apoQlar
apoQlar is a pioneering company in the healthcare technology sector, specializing in the development of mixed reality solutions for medical professionals. Their flagship product, VSI HoloMedicine, utilizes Microsoft HoloLens 2 hardware to convert traditional medical images and workflows into an immersive 3D mixed reality environment. This technology significantly enhances the way medical professionals practice, experience, learn, and share medical knowledge globally. The primary clients include professors, physicians, and medical institutions who benefit from reduced cognitive overload during complex procedures and improved collaborative capabilities. Operating in the global healthcare market, apoQlar's business model revolves around software licensing and service fees, generating revenue through the adoption of their innovative HoloMedicine platform. The company has been recognized as a finalist for the 2020 Microsoft Partner of the Year Awards and has won the Novartis Digital Health Award, underscoring its impact and innovation in the medical field.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Hamburg, Germany
- Employees
- 51
- Open positions
- 2
- Dealroom signal
- 60.6/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech
- Technology
- Artificial Intelligence, 3D Technology, Big Data, Deep Tech, Machine Learning, Augmented Reality, Virtual Reality, Computer Vision, Connected Device
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $11M | $44M | IFB Innovationsstarter · YZR Capital | ↗ |
| EARLY VC✓Equity / VC | Jul 2023 | $0 | — | YZR Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for apoQlar is 120 monthly website visits, up 33.3% over the last three months. apoQlar's team declined 7.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
YZR Capital
IFB Innovationsstarter
Other known investors2 additional known investors
German Accelerator- JHJana Hecker
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about apoQlar on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See apoQlar’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.